- Tytuł:
- WAVELINE‐004: OPEN‐LABEL, PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (MK‐2140) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL).
- Autorzy:
- Temat:
-
DIFFUSE large B-cell lymphomas
TUMOR lysis syndrome
CARCINOEMBRYONIC antigen - Źródło:
- Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p208-209, 2p
Czasopismo naukowe